IL-21–mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytes
Open Access
- 1 January 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (1) , 229-235
- https://doi.org/10.1182/blood-2007-05-089375
Abstract
Efforts to reproducibly isolate tumor antigen–specific T cells from patients would be facilitated by removing immunoregulatory barriers. Using a human model for eliciting T-cell responses to tumor-associated antigens, we develop a novel strategy that eliminates nearly all Foxp3-expressing cells through the combination of CD25 depletion and IL-21 treatment resulting in a more than 150-fold decrease in Foxp3+ cells to virtually undetectable levels and a more than 200-fold increase in antigen-specific cytotoxic T lymphocytes (CTLs). The extent of Foxp3 elimination and degree of expansion of antigen-specific CTLs shown in this study have not previously been achievable and are unique to IL-21. We demonstrate for the first time a possible mechanism for IL-21–mediated expansion of antigen-specific CTLs that involves suppression of Foxp3-expressing cells and reversal of inhibition to tumor-associated antigen–specific CTL generation in vitro. Taken together, the combination of CD25 depletion and IL-21 exposure, by releasing regulatory constraints, leads to markedly enhanced CTL induction and represents a robust strategy for the ex vivo generation of antigen-specific T cells for adoptive cellular therapy.Keywords
This publication has 32 references indexed in Scilit:
- Identification of a human CD8+regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4Proceedings of the National Academy of Sciences, 2007
- Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunityNature Genetics, 2007
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Recruitment of latent pools of high-avidity CD8+ T cells to the antitumor immune responseThe Journal of Experimental Medicine, 2005
- NaturallyArisingCD4+RegulatoryT Cells forImmunologicSelf-Tolerance andNegativeControl ofImmuneResponsesAnnual Review of Immunology, 2004
- Adoptive-cell-transfer therapy for the treatment of patients with cancerNature Reviews Cancer, 2003
- A Critical Role for IL-21 in Regulating Immunoglobulin ProductionScience, 2002
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- Cancer antigens: immune recognition of self and altered self.The Journal of Experimental Medicine, 1994